FastBack Bio
Raleigh, US · Founded 2020 · North Carolina LLC
Biotechnology company developing CAR-T therapeutics using a novel M83 co-stimulatory domain platform for enhanced efficacy against solid tumors.
Founders & leadership
Board
AS
ABRAHAM SURINDER MAINGIBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2020
▶$1.8MraisedNov 2020 · 10 investors · BiotechnologyRule 506(b)
▶$1.8MraisedNov 2020 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- SHAILESH MAINGIPromoter
- ABRAHAM SURINDER MAINGIExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Nov 2020
- Incorporated
- Limited Liability Company, North Carolina, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does FastBack Bio do?
- Biotechnology company developing CAR-T therapeutics using a novel M83 co-stimulatory domain platform for enhanced efficacy against solid tumors.
- How much funding has FastBack Bio raised?
- FastBack Bio has disclosed $1.8M raised across 1 round.
- Where is FastBack Bio headquartered?
- FastBack Bio is headquartered in Raleigh, US.